According to Harvard Bioscience's latest financial reports the company's current earnings are HK$0.10 Billion. In 2023 the company made an earning of -HK$19.9 Million, an increase over its 2022 earnings that were of -HK$71.46 Million. The earnings displayed on this page is the company's Pretax Income.